DeepMed Research

Georgetown University

🇬🇹Guatemala

Country: 🇬🇹Guatemala

Ownership: Private

Established: 1789-01-23

Employees: 5K

Market Cap: -

Website: http://www.georgetown.edu

Clinical Trials

Effects of a Structured Exercise Program on Cancer-Related Fatigue in Women Receiving Radiation Therapy for Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Other: Physical Activity

First Posted Date: 2014-04-17

Last Posted Date: 2020-01-27

Lead Sponsor: Georgetown University

Target Recruit Count: 27

Registration Number: NCT02117011

Locations: 🇺🇸
Washington Cancer Institute at Washington Hospital Center, Washington, District of Columbia, United States

Quit and Fit: A Tobacco Cessation and Energy Balance Pilot for African Americans

Not Applicable

Completed

Conditions: Smoking Cessation

Interventions: Other: Intervention

First Posted Date: 2014-04-04

Last Posted Date: 2017-11-29

Lead Sponsor: Georgetown University

Target Recruit Count: 40

Registration Number: NCT02103582

Locations: 🇺🇸
Georgetown University Lombardi community site office, Washington, District of Columbia, United States

Open Label Treatment With tDCS for Parkinson's and Related Disorders for Improvement of Speech, Gait and Mood

Phase 1

Completed

Conditions: Parkinson's Disease

Interventions: Device: tDCS

First Posted Date: 2014-04-04

Last Posted Date: 2014-08-20

Lead Sponsor: Georgetown University

Target Recruit Count: 10

Registration Number: NCT02104401

Locations: 🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States

An Exercise RCT Targeting African-American Women With Metabolic Syndrome and High Risk for Breast Cancer

Not Applicable

Active, not recruiting

Conditions: Obesity
Metabolic Syndrome

Interventions: Behavioral: Facility-based Exercise
Behavioral: Home-based Exercise

First Posted Date: 2014-04-03

Last Posted Date: 2024-02-20

Lead Sponsor: Georgetown University

Target Recruit Count: 213

Registration Number: NCT02103140

Locations: 🇺🇸
Georgetown Lombardi Office of Minority Health community site, Washington, District of Columbia, United States

Non-Invasive Evaluation of Transplant Kidney Using OCT

Not Applicable

Completed

Conditions: Chronic Kidney Disease

First Posted Date: 2014-03-12

Last Posted Date: 2019-03-08

Lead Sponsor: Georgetown University

Target Recruit Count: 169

Registration Number: NCT02084966

Locations: 🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States

Myobloc Atrophy Study

Phase 4

Completed

Conditions: Spasticity Secondary to Either a Disorder or Trauma
Spinal Cord Injury (SCI)
Stroke
Brain Injury
Tumor

Interventions: Drug: MYOBLOC
Drug: Botox

First Posted Date: 2014-01-31

Last Posted Date: 2015-12-16

Lead Sponsor: Georgetown University

Target Recruit Count: 10

Registration Number: NCT02052024

Locations: 🇺🇸
Medstar Georgetown University Hospital, Washington, District of Columbia, United States

Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers

Phase 4

Terminated

Conditions: Type II Diabetes

Interventions: Drug: Placebo
Drug: Sitagliptin

First Posted Date: 2013-12-19

Last Posted Date: 2017-01-06

Lead Sponsor: Georgetown University

Target Recruit Count: 1

Registration Number: NCT02015910

Locations: 🇺🇸
Medstar Georgetown University Hospital, Washington, District of Columbia, United States

Metabolomic Study for Localized Prostate Cancer

Conditions: Prostate Cancer

Interventions: Radiation: Radiation Therapy

First Posted Date: 2013-10-24

Last Posted Date: 2023-02-28

Lead Sponsor: Georgetown University

Target Recruit Count: 400

Registration Number: NCT01968538

Locations: 🇺🇸
Georgetown University Hospital, Arlington, Virginia, United States

Comparing Outcomes for Prontosan Versus Normal Saline for Negative Pressure Wound Therapy With Instillation

Phase 4

Completed

Conditions: Wound Infection

Interventions: Drug: Normal saline
Device: Prontosan

First Posted Date: 2013-09-11

Last Posted Date: 2016-12-29

Lead Sponsor: Georgetown University

Target Recruit Count: 100

Registration Number: NCT01939145

Locations: 🇺🇸
Medstar Georgetown University Hospital Center for Wound Healing, Washington, District of Columbia, United States

Molecularly Tailored Therapy for Pancreas Cancer

Phase 2

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: Modified FOLFOX-6
Drug: Ox-Tax
Drug: FOLFIRI
Drug: Tax-Iri
Drug: Gem-OX
Drug: Gem-5FU
Drug: Gem-Tax

First Posted Date: 2013-06-28

Last Posted Date: 2018-04-09

Lead Sponsor: Georgetown University

Target Recruit Count: 19

Registration Number: NCT01888978

Locations: 🇺🇸
MedStar Montgomery Medical Center, Olney, Maryland, United States
🇺🇸
Georgetown University- Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy